Literature DB >> 10682219

Search for schizophrenia susceptibility genes.

A E Pulver1.   

Abstract

Identification of a gene or genes that contribute to the development of schizophrenia, a complex psychiatric disorder, may be possible through genetic linkage analysis. Although to date no single causative gene has been identified, several chromosomal loci have shown positive linkage results and are under investigation as tentative schizophrenia susceptibility loci. Despite such obstacles as locus heterogeneity among sample populations, epistatic inheritance models, and failure to obtain statistical significance in studies, patterns have emerged that focus research efforts on chromosomes 13, 8, 22, and 6 and 10. Initial heterogeneity analyses suggests that identifiable subgroups of the families may not contribute equally to these linkage findings. Findings on several additional chromosomes await further replication. Future progress in the search for schizophrenia susceptibility genes will require collaboration among researchers from both academia and industry.

Entities:  

Mesh:

Year:  2000        PMID: 10682219     DOI: 10.1016/s0006-3223(99)00281-4

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  23 in total

1.  Retroviruses and the pathogenesis of schizophrenia.

Authors:  D A Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

Review 2.  Animal models of schizophrenia: a critical review.

Authors:  E R Marcotte; D M Pearson; L K Srivastava
Journal:  J Psychiatry Neurosci       Date:  2001-11       Impact factor: 6.186

Review 3.  Paternal factors and schizophrenia risk: de novo mutations and imprinting.

Authors:  D Malaspina
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

Review 4.  Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes.

Authors:  William R Perlman; Cynthia Shannon Weickert; Mayada Akil; Joel E Kleinman
Journal:  J Psychiatry Neurosci       Date:  2004-07       Impact factor: 6.186

Review 5.  Mitochondria in complex psychiatric disorders: Lessons from mouse models of 22q11.2 deletion syndrome: Hemizygous deletion of several mitochondrial genes in the 22q11.2 genomic region can lead to symptoms associated with neuropsychiatric disease.

Authors:  Prakash Devaraju; Stanislav S Zakharenko
Journal:  Bioessays       Date:  2017-01-03       Impact factor: 4.345

6.  Structural MRI of the brain in presumed carriers of genes for schizophrenia, their affected and unaffected siblings.

Authors:  R M Steel; H C Whalley; P Miller; J J K Best; E C Johnstone; S M Lawrie
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

7.  A highly significant association between a COMT haplotype and schizophrenia.

Authors:  Sagiv Shifman; Michal Bronstein; Meira Sternfeld; Anne Pisanté-Shalom; Efrat Lev-Lehman; Avraham Weizman; Ilya Reznik; Baruch Spivak; Nimrod Grisaru; Leon Karp; Richard Schiffer; Moshe Kotler; Rael D Strous; Marnina Swartz-Vanetik; Haim Y Knobler; Eilat Shinar; Jacques S Beckmann; Benjamin Yakir; Neil Risch; Naomi B Zak; Ariel Darvasi
Journal:  Am J Hum Genet       Date:  2002-10-25       Impact factor: 11.025

8.  Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion.

Authors:  Sungkun Chun; Fei Du; Joby J Westmoreland; Seung Baek Han; Yong-Dong Wang; Donnie Eddins; Ildar T Bayazitov; Prakash Devaraju; Jing Yu; Marcia M Mellado Lagarde; Kara Anderson; Stanislav S Zakharenko
Journal:  Nat Med       Date:  2016-11-28       Impact factor: 53.440

Review 9.  Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.

Authors:  Emma Perez-Costas; Miguel Melendez-Ferro; Rosalinda C Roberts
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

Review 10.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.